Published in Kidney Int Suppl on February 01, 2003
Population based screening for chronic kidney disease: cost effectiveness study. BMJ (2010) 2.19
The burden of chronic kidney disease. BMJ (2006) 1.57
Early detection of chronic kidney disease: results of the PolNef study. Am J Nephrol (2008) 0.92
Efficacy of urine screening at school: experience in Shanghai, China. Pediatr Nephrol (2007) 0.84
Active collaboration with primary care providers increases specialist referral in chronic renal disease. BMC Nephrol (2004) 0.84
Limited knowledge of chronic kidney disease among primary care patients--a cross-sectional survey. BMC Nephrol (2012) 0.83
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49
Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int (2003) 2.04
Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol (2007) 1.98
Cardiovascular risk factors in CKD associate with both ESRD and mortality. J Am Soc Nephrol (2013) 1.78
A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo. Cancer Res (2006) 1.67
Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. Clin J Am Soc Nephrol (2011) 1.62
Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis (2012) 1.61
Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med (2006) 1.55
Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol (2010) 1.51
Oxidative Balance Score and Chronic Kidney Disease. Am J Nephrol (2015) 1.42
Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis (2009) 1.40
History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol (2004) 1.35
Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis (2011) 1.31
Correlation of renal histopathology with sonographic findings. Kidney Int (2005) 1.29
Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. Clin J Am Soc Nephrol (2011) 1.26
Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol (2002) 1.26
Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD Clinical Performance Measures Project. Am J Kidney Dis (2008) 1.22
Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis (2008) 1.15
Racial disparities in access to pediatric kidney transplantation since share 35. J Am Soc Nephrol (2012) 1.14
Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline results. Kidney Int (2005) 1.13
Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. Nephrol Dial Transplant (2006) 1.12
Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients. Nephrol Dial Transplant (2007) 1.11
Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study. BMC Nephrol (2009) 1.08
Incidence of stroke symptoms among adults with chronic kidney disease: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Nephrol Dial Transplant (2011) 1.08
Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol (2008) 1.06
Association of standing-order policies with vaccination rates in dialysis clinics: a US-based cross-sectional study. Am J Kidney Dis (2009) 1.06
Racial and gender differences in arteriovenous fistula use among incident hemodialysis patients. Am J Nephrol (2010) 1.04
Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nat Med (2013) 1.02
Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis (2012) 1.02
Associations of dietary fat with albuminuria and kidney dysfunction. Am J Clin Nutr (2010) 0.99
Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis. J Histochem Cytochem (2008) 0.98
Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution. J Med Chem (2004) 0.95
The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain. Nucleic Acids Res (2004) 0.94
Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients with lupus nephritis. Hum Pathol (2006) 0.93
In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy. Virchows Arch (2005) 0.91
A nearly unavoidable mechanism for collider bias with index-event studies. Epidemiology (2014) 0.90
Regional variability in anaemia management and haemoglobin in the US. Nephrol Dial Transplant (2003) 0.89
Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis (2002) 0.88
Association between ideal cardiovascular health and carotid intima-media thickness: a twin study. J Am Heart Assoc (2014) 0.88
The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1. Virology (2003) 0.87
Clinical characteristics of patients with early hospital arrival after stroke symptom onset. J Stroke Cerebrovasc Dis (2007) 0.87
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am J Hypertens (2012) 0.86
CRM1-mediated nuclear export is required for 26 S proteasome-dependent degradation of the TRIP-Br2 proto-oncoprotein. J Biol Chem (2008) 0.86
TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability. Cell Cycle (2004) 0.84
Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma. Cancer (2013) 0.83
Hemoglobin concentration and cognitive impairment in the renal REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. J Gerontol A Biol Sci Med Sci (2010) 0.83
Hypoalbuminemia predicts acute stroke mortality: Paul Coverdell Georgia Stroke Registry. J Stroke Cerebrovasc Dis (2010) 0.81
Pre-end-stage renal disease care not associated with dialysis facility neighborhood poverty in the United States. Am J Nephrol (2014) 0.81
Veterans more likely to start hemodialysis with an arteriovenous fistula. Semin Dial (2011) 0.81
Paradigms of public-private partnerships in end-stage renal disease care: the National Kidney Foundation Singapore. Kidney Int Suppl (2003) 0.81
The TRIP-Br family of transcriptional regulators is essential for the execution of cyclin E-mediated cell cycle progression. Cell Cycle (2006) 0.81
Kidney transplantation and the intensity of poverty in the contiguous United States. Transplantation (2014) 0.80
A group-randomized evaluation of a quality improvement intervention to improve influenza vaccination rates in dialysis centers. Am J Kidney Dis (2010) 0.80
The ABCDEs of CKD: a simple approach to early detection and management. South Med J (2008) 0.79
Coupled induction of iNOS and p53 upregulation in renal resident cells may be linked with apoptotic activity in the pathogenesis of progressive IgA nephropathy. J Am Soc Nephrol (2004) 0.79
Identification of PP2A as a novel interactor and regulator of TRIP-Br1. Cell Signal (2008) 0.78
Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. Am J Med Sci (2013) 0.77
Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer. Cancer Biol Ther (2007) 0.77
Administrative data as a tool for arthritis surveillance: estimating prevalence and utilization of services. J Public Health Manag Pract (2003) 0.77
Risk for progression to ESRD: Further evidence from population-based studies. J Am Soc Nephrol (2006) 0.76
The effect of external feedback on the management of medicare inpatients with congestive heart failure. Am J Med Qual (2002) 0.76
Development and validation of a self-assessment tool for albuminuria: results from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2011) 0.76
Processes of care and reduced mortality among hemodialysis patients in the United States. Clin J Am Soc Nephrol (2010) 0.75
Breast cancer screening and dialysis: too much or too little. Am J Kidney Dis (2008) 0.75
Prevalence and treatment of anemia with once-weekly epoetin alfa in patients with diabetes and chronic kidney disease. Endocr Pract (2006) 0.75
Survival patterns of lead-exposed workers with end-stage renal disease from Adult Blood Lead Epidemiology and Surveillance program. Am J Med Sci (2015) 0.75
Diseases of the kidney: molecular mechanisms and current therapy. Curr Mol Med (2005) 0.75
Outcomes in Hepatocellular Carcinoma Liver Transplantation before and after the Mandated Six-Month Wait Time. Am Surg (2019) 0.75
As to diseases, make a habit of two things - to help, or at least do no harm. J Am Soc Nephrol (2002) 0.75
Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service. Am J Kidney Dis (2002) 0.75
Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease. Am J Nephrol (2017) 0.75